PF-Atlas › Clinical Trials › NCT06135363
Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects
SC1011 · Phase 1
Registry ID
NCT06135363
Phase
Phase 1
Status
Completed
Drug / intervention
SC1011
Sponsor
Guangzhou JOYO Pharma Co., Ltd
Start
2022-08-11
Enrollment
45
Locations
1
About this trial
The goal of this clinical trial is to learn about the safety, tolerability and pharmacokinetic profiles of SC1011 in healthy conditions. The main questions it aims to answer are: Safety and tolerability profiles in healthy subjects and pharmacokinetic profiles in healthy subjects. Participants will complete the study including screening period, dosing period, and observation period. Investigators will compare the inhibitory activity of SC1011 tablets with pirfenidone capsules against the same biomarkers(e.g. blood TNFα) to see if they are different between the two drugs.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT06135363 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.